2011-11-15T10:42:25-06:00 2010-12-31 WARREN AVERETT KIMBROUGH & MARINO LLC 2500 ACTON ROAD BIRMINGHAM AL 35243 990 2010-01-02 630288868 SOUTHERN RESEARCH INSTITUTE SOUT 2055812000 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 352555305 DAVID RUTLEDGE 2055812000 2011-11-14 1 2059794100 2010 2016-03-07 17:11:31Z DAVID RUTLEDGE 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 352555305 96122257 0 X WWW.SOUTHERNRESEARCH.ORG X 1941 AL TO OFFER RESEARCH & TECHNOLOGY SERVICES TO SUPPORT INDUSTRY AND FEDERAL GOVERNMENT AGENCIES. 9 9 603 0 869248 -27832 99615 76822 83653452 89828510 4119871 6077038 -42958 23075 87829980 96005445 60145 39150 0 0 43426748 44423338 0 0 0 38543879 41735946 82030772 86198434 5799208 9807011 128437539 165483524 13366445 36488102 115071094 128995422 X TO OFFER RESEARCH AND TECHNOLOGY SERVICES TO SUPPORT THE LIFE SCIENCES, ENGINEERING, ENERGY, AND ENVIRONMENTAL PROTECTION INDUSTRIES. THE ORGANIZATION PURSUES ENTREPRENEURIAL AND COLLABORATIVE INITIATIVES TO DEVELOP AND MAINTAIN A PIPLELINE OF INTELLECTUAL PROPERTY AND INNOVATIVE TECHNOLOGIES THAT CONTRIBUTE TO THE GROWTH OF THE ORGANIZATION AND POSITIVELY IMPACT REAL-WORLD PROBLEMS. 0 0 30328315 DRUG DEVELOPMENT PROVIDES DRUG DISCOVERY AND PRE-CLINICAL DRUG DEVELOPMENT TO PHARMACEUTICAL AND BIOTECHNOLOGY ON AN OUTSOURCED BASIS. SOUTHERN RESEARCH INSTITUTE HAS CAPABILITIES IN ALL PHASES OF THE EARLY-STAGE DRUG DISCOVERY AND DEVELOPMENT PROCESS AND PROVIDES CLIENTS WITH COMPREHENSIVE SERVICES AND SUPPORT TO ASSIST THEM IN STREAMLINING THEIR CUSTOM DRUG DISCOVERY AND DEVELOPMENT PROGRAMS. SOME OF SOUTHERN RESEARCH INSTITUTE'S SIGNIFICANT PRE-CLINICAL RESEARCH ACCOMPLISHMENTS INCLUDE: DEMONSTRATED THE EFFICACY OF COMBINATION CHEMOTHERAPY IN MICE, LEADING THE WAY FOR THE DEVELOPMENT OF THERAPEUTIC APPROACHES WITH IMPROVED CLINICAL OUTCOMES IN CERTAIN CANCERS, PERFORMED PRE-CLINICAL DRUG DEVELOPMENT EVALUATIONS AND ANALYSES ON APPROXIMATELY HALF OF THE FDA-APPROVED CANCER THERAPEUTICS CURRENTLY ON THE MARKET, AND CONTRIBUTED TO THE DEVELOPMENT OF THE FIRST DRUG DELIVERY TECHNOLOGY FOR THE EXTENDED RELEASE OF SYNTHETIC AGENTS THAT PROMOTE THE TREATMENT OF PROSTATE CANCER. 24504488 THE ENGINEERING DIVISION DEVELOPS ENGINEERING SOLUTIONS TO COMPLEX PROBLEMS THROUGH CHARACTERIZING THE MECHANICAL, THERMAL, PHYSICAL, AND CHEMICAL PROPERTIES OF ADVANCED MATERIALS. THE ENGINEERING DIVISION IS ALSO DEVELOPING NEW, LOW-COST PROCESSES TO PRODUCE CARBON/CARBON AND POLYMER MATRIX COMPOSITE MATERIALS AND AEROGELS (ULTRA-LIGHT FOAM), AS WELL AS PROCESSING METHODS TO FABRICATE THESE MATERIALS FOR A WIDE VARIETY OF APPLICATIONS FROM AUTOMOTIVE AND RECREATIONAL PRODUCTS TO THE MOST ADVANCED AEROSPACE APPLICATIONS. SOUTHERN RESEARCH INSTITUTE ALSO PROVIDES ENVIRONMENTAL RESEARCH AND SERVICES TO GOVERNMENT, INDUSTRY, AND PRIVATE INSTITUTIONS. THE RESEARCH HAS LED TO THE DEVELOPMENT OF NEW TEST METHODS AND INSTRUMENTS, THE IMPROVEMENT OF PROCESS AND EMISSION CONTROL TECHNOLOGIES, SOLUTIONS TO DAUNTING NEW ENVIRONMENTAL CHALLENGES, AND OTHER IMPORTANT CONTRIBUTIONS TO ENVIRONMENTAL SCIENCES. 14133774 DRUG DISCOVERY HAS ACCOMPLISHED INNOVATIVE RESEARCH IN THE AREAS OF CANCER, INFECTIOUS DISEASE, AND NEUROSCIENCE. WITH A FOCUS ON THE DISCOVERY OF NEW, SMALL-MOLECULE THERAPEUTICS AND THE UNDERSTANDING OF HOW THESE MOLECULES WORK, DRUG DISCOVERY CARRIES OUT TRANSLATIONAL SCIENCE DESIGNED TO INVENT SMALL MOLECULES AND ADVANCE THEM FROM THE DESIGN STAGE TO THE CLINIC. GOVERNMENT FUNDING SUPPORTS OUR EFFORTS IN PIONEERING NEW SCIENTIFIC AREAS OF DRUG DISCOVERY. THE DRUG DISCOVERY STAFF PROVIDES EXPERTISE IN MEDICINAL CHEMISTRY, MOLECULAR BIOLOGY, BIOCHEMISTRY, AND HIGH-THROUGHPUT SCREENING TECHNOLOGIES, ALL FOCUSED ON MAKING DISCOVERIES THAT WILL CONTRIBUTE TO IMPROVING HUMAN HEALTH. THE DRUG DISCOVERY TEAM HAS BEEN VERY EFFECTIVE IN ITS EFFORTS AND HAS DISCOVERED MORE THAN 20 DRUGS THAT HAVE ENTERED CLINICAL TRIALS AND SIX DRUGS THAT HAVE BEEN APPROVED BY THE FDA FOR USE IN THE TREATMENT OF CANCER. 68966577 1 1 0 1 0 0 0 0 1 1 0 0 1 1 0 1 1 0 1 1 0 0 0 0 0 0 1 0 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 1 119 0 1 603 1 1 1 0 0 0 0 0 0 0 0 0 X 9 9 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 0 1 1 0 X DAVID RUTLEDGE 2055812000 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 352555305 CAROL Z GARRISON 0.00 X 0 616917 130756 SHIRLEY SALLOWAY KAHN 0.00 X 0 337909 78758 RICHARD L MARGISON 0.00 X 0 369422 64717 H CORBIN DAY 0.00 X 0 0 0 WILLIAM W FEATHERINGILL 0.00 X 0 0 0 CHARLES K PORTER 0.00 X 0 0 0 MALCOLM PORTERA 0.00 X 0 625599 117513 FOURNIER J GALE III 0.00 X 0 0 0 CHARLES MCCRARY 0.00 X 0 0 0 JOHN A SECRIST III PHD 40.00 X 339010 0 61884 DAVID A RUTLEDGE 40.00 X 193708 0 27952 NANCY M GRAY 40.00 X 222579 0 45045 ANDREW D PENMAN 40.00 X 260114 0 39546 WILSON B KNIGHT 40.00 X 271875 0 26901 MICHAEL D JOHNS 40.00 X 206557 0 40067 ROBERT L MCCLURE 40.00 X 185905 0 44876 BRENDA H EHRENSPERGER 40.00 X 147300 0 29991 JILL B CORDLE 40.00 X 134738 0 3686 DAVID W MASON 40.00 X 121269 0 38506 WILLIAM R WAUD 40.00 X 189030 0 38463 MICHAEL G MURRAY 40.00 X 199983 0 23841 MARTIN V JONES 40.00 X 225878 0 20381 ANITA T FOWLER 40.00 X 201109 0 31782 SCOTT F GELLER 40.00 X 236254 0 19383 3135309 1949847 884048 73 0 1 0 SLOAN KETTERING INSTITUTE PO BOX 27718 NEW YORK NY 10087 INTELLECTUAL PROPERTY 2184182 UT STATE UNIVERSITY 2400 OLD MAIN HILL LOGAN UT 843222400 SUBCONTRACT SERVICES 2166247 KELLY SERVICES INC PO BOX 530437 ATLANTA GA 303530437 TEMPORARY EMPLOYEES 1639487 JEFFREY BROWN CONTRACTING 400 E JOPPA ROAD SUITE 400 TOWSON MD 21286 CONTRACT SERVICES 762051 UNIVERSITY OF ALABAMA AT BIRMINGHAM 1530 3RD AVENEUE SOUTH BIRMINGHAM AL 352941150 CONTRACT & ADMINISTRATIVE SERVICES 756364 68 76822 76822 CONTRACTS 541900 82606464 81737216 869248 INTELLECTUAL PROPERTY 541900 7222046 7222046 89828510 1268881 1268881 78860 63019 15841 15841 15841 4820245 41705 53793 4820245 -12088 4808157 4808157 MISCELLANEOUS 900099 7234 7234 7234 96005445 81744450 869248 13314925 39150 39150 2083054 1666443 416611 29109320 23287456 5821864 13230964 10584771 2646193 140747 112598 28149 187770 150216 37554 169387 135510 33877 5000 4000 1000 9033863 7227090 1806773 10278548 8222838 2055710 4248448 3398758 849690 1129214 903371 225843 5933481 4746785 1186696 878746 702997 175749 OTHER DIRECT COSTS 4478242 3582594 895648 EQUIPMENT MAINTENANCE 1888595 1510876 377719 DIRECT ANIMAL CARE 1591788 1273430 318358 MARKETING 573027 458422 114605 DUES & SUBSCRIPTIONS 420083 336066 84017 779007 623206 155801 86198434 68966577 17231857 0 58070 21810880 8302 9200 13597696 14579579 873217 955270 1888191 1933802 113927011 56943933 55996616 56983078 50523523 56036566 5491924 13175149 128437539 165483524 10548966 13095531 1545595 2719431 20000000 736139 535745 673140 13366445 36488102 X 106890333 119586048 8180761 9409374 115071094 128995422 128437539 165483524 X 9807011 4117317 X X 0 1 1 X 1 1 X 42342 160834 96769 99615 76822 476382 72761126 71594704 74184779 81844503 88959262 389344374 4519 57345 371 7234 69469 72803468 71760057 74338893 81944489 89043318 389890225 0 0 0 389890225 815133 1982005 1449548 1183992 1347741 6778419 2651699 4792556 5608133 1808949 869248 15730585 3466832 6774561 7057681 2992941 2216989 22509004 76270300 78534618 81396574 84937430 91260307 412399229 0.94540 0.94190 0.05460 0.05810 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 1 16111 0 1 169387 185498 0 EXPLANATION OF OTHER LOBBYING ACTIVITIES: PART II-B, LINE 1I: DURING THE YEAR, SRI CONTRACTED WITH THIRD PARTIES TO MONITOR AND EVALUATE VARIOUS LEGISLATIVE ISSUES. 8180761 1246975 18362 9409374 6860965 1566975 230000 17179 8180761 8892035 -1993440 37630 6860965 1.00000 0 0 6375603 6375603 59739229 29720802 30018427 1007399 916347 91052 43064436 26306784 16757652 3740344 3740344 56983078 PATENTS, NET OF ACCUMULATED AMORTIZATION 1847135 OTHER RECEIVABLES 11076997 GOODWILL 50000 CAPITALIZED VACCINE COSTS 36663 BOND ISSUE COSTS 164354 13175149 POST RETIREMENT BENEFITS 673140 673140 96005445 86198434 9807011 4117317 4117317 13924328 100176831 4117317 63019 4180336 95996495 8950 8950 96005445 86252503 63019 63019 86189484 8950 8950 86198434 DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: PART V, LINE 4: THE INTENDED USE OF THE FUNDS IS TO HELP CERTAIN OUTSTANDING NEWLY-HIRED SCIENTISTS GET THEIR LABORATORIES ESTABLISHED BEFORE THEY HAVE SECURED FUNDING FROM OUTSIDE SPONSORS. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES SHOWN AS OFFSET TO REVENUE IN THE RETURN 63,019. PART XII, LINE 4B - OTHER ADJUSTMENTS: EXPENSE SHOWN AS OFFSET TO INCOME ON BOOKS 8,950. PART XIII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES SHOWN AS OFFSET TO REVENUE IN THE RETURN 63,019. PART XIII, LINE 4B - OTHER ADJUSTMENTS: EXPENSE SHOWN AS OFFSET TO INCOME ON BOOKS 8,950. RUSSIA AND THE NEWLY INDEPENDENT STATES 6 PROGRAM SERVICES CONSULTANT ASSISTING INTEGRATING CONTRACTOR IN SUPPORT OF THE DEFENSE THREAT REDUCTION AGENCY'S BIOLOGICAL THREAT REDUCTION INTEGRATING CONTRACT 2009784 6 0 6 2009784 0 2009784 0 0 0 0 0 0 1 UNITED WAY OF CENTRAL ALABAMA PO BOX 320189 BIRMINGHAM AL 352320189 630288846 501(C)(3) 15000 GENERAL SUPPORT THE ECONOMIC DELVELOPMENT PARTNERSHIP OF ALABAMA INC 500 BEACON PARKWAY WEST BIRMINGHAM AL 352093144 581904013 501(C)(6) 10000 GENERAL SUPPORT 1 1 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: THE ORGANIZATION REVIEWS ANY GRANTS MADE TO ENSURE THEY ARE QUALIFYING RECIPIENTS. NO FURTHER SUBSTANTIATION OF USE OR ADDITIONAL REVIEW IS DONE. X 1 1 X X X X X 0 1 0 0 0 0 0 0 0 CAROL Z GARRISON 0 484171 0 128541 0 4205 0 96510 0 37427 0 750854 0 0 SHIRLEY SALLOWAY KAHN 0 294440 0 42102 0 1367 0 56067 0 24688 0 418664 0 0 RICHARD L MARGISON 0 315020 0 43588 0 10814 0 53616 0 13189 0 436227 0 0 MALCOLM PORTERA 0 508004 0 104541 0 13054 0 102729 0 14784 0 743112 0 0 JOHN A SECRIST III PHD 326015 0 1167 0 11828 0 56878 0 5006 0 400894 0 0 0 DAVID A RUTLEDGE 192223 0 0 0 1485 0 23590 0 4362 0 221660 0 0 0 NANCY M GRAY 209388 0 12000 0 1191 0 39217 0 5828 0 267624 0 0 0 ANDREW D PENMAN 259699 0 0 0 415 0 36100 0 3446 0 299660 0 0 0 WILSON B KNIGHT 224178 0 21600 0 26097 0 26901 0 0 0 298776 0 0 0 MICHAEL D JOHNS 206308 0 0 0 249 0 33528 0 6539 0 246624 0 0 0 ROBERT L MCCLURE 184714 0 0 0 1191 0 39784 0 5092 0 230781 0 0 0 BRENDA H EHRENSPERGER 146120 0 0 0 1180 0 26545 0 3446 0 177291 0 0 0 DAVID W MASON 119307 0 1000 0 962 0 32060 0 6446 0 159775 0 0 0 WILLIAM R WAUD 152775 0 32927 0 3328 0 34536 0 3927 0 227493 0 0 0 MICHAEL G MURRAY 196346 0 0 0 3637 0 23591 0 250 0 223824 0 0 0 MARTIN V JONES 128411 0 1000 0 96467 0 15942 0 4439 0 246259 0 0 0 ANITA T FOWLER 68111 0 132373 0 625 0 27770 0 4012 0 232891 0 0 0 SCOTT F GELLER 129009 0 1000 0 106245 0 15542 0 3841 0 255637 0 0 0 THE COOPERATIVE DISTRICT OF THE CITY OF BIRMINGHAM-SOUTHERN RESEARCH INST 273338884 NONEAVAIL 2010-08-31 20000000 SOUTHSIDE AND OXMOOR CAMPUS CAPITAL IMPROVEMENTS 0 1 0 20000000 174000 710458 19115542 0 0 0 1 0 0 0 1 1 1 0 1 0 0 0 1 MAYNARD COOPER & GALE PC FOURNIER J. GALE, III IS A SHAREHOLDER OF THE ABOVE ENTITY 226825 LEGAL SERVICES 0 PORTER WHITE & COMPANY CHARLES K. PORTER IS AN OFFICER OF THE ABOVE ENTITY 189958 FINANCIAL ADVISORY SERVICES 0 ALABAMA POWER COMPANY CHARLES MCCRARY & MALCOLM PORTERA ARE DIRECTORS OF THE ABOVE ENTITY 2334148 ELECTRICITY & STEAM 0 THE UNIVERSITY OF ALABAMA AT BIRMINGHAM SHIRLEY SALLOWAY KAHN IS AN OFFICER OF THE ABOVE ENTITY 756364 CONTRACT SERVICES 0 THE UNIVERSITY OF ALABAMA AT BIRMINGHAM RICHARD L. MARGISON IS AN OFFICER OF THE ABOVE ENTITY 756364 CONTRACT SERVICES 0 THE UNIVERSITY OF ALABAMA AT BIRMINGHAM CAROL Z. GARRISON IS AN OFFICER OF THE ABOVE ENTITY 756364 CONTRACT SERVICES 0 FORM 990, PART VI, SECTION B, LINE 11 THE BOARD OF DIRECTORS HAS ADOPTED THE POLICY THAT THE FINANCE COMMITTEE WOULD REVIEW AND APPROVE THE FORM 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C OFFICERS, DIRECTORS, AND KEY/HIGHLY COMPENSATED EMPLOYEES ARE REQUIRED TO DISCLOSE ANNUALLY ANY POTENTIAL CONFLICTS OF INTEREST OR CERTIFY THAT NO SUCH CONFLICTS EXIST. THE ORGANIZATION INVESTIGATES DISCLOSURES OF ANY POTENTIAL CONFLICTS AND TAKES STEPS TO MITIGATE THE OCCURRENCE OF ACTUAL CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 FOR THE COMPENSATION OF ITS EXECUTIVE MANAGEMENT, SOUTHERN RESEARCH INSTITUTE HIRES AN OUTSIDE FIRM TO MAKE RECOMMENDATIONS FOR MARKET TARGETS AND THEN AGES THE TARGETS SLIGHTLY EACH YEAR. AN OUTSIDE FIRM ALSO PROVIDES THE COMPENSATION COMMITTEE WITH A LETTER REGARDING PAY PRACTICES AND INTERMEDIATE SANCTIONS. HUMAN RESOURCES USES EXTERNAL MARKET DATA TO ESTABLISH A MARKET TARGET AND SALARY RANGES FOR THE COMPENSATION OF KEY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 AS A GENERAL RULE, THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, OR FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. ANY WRITTEN REQUEST BY THE PUBLIC WOULD BE REVIEWED AND ACTED UPON BY THE BOARD. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED GAINS ON INVESTMENTS: 4,117,317. FORM 990, PART XII, LINE 2C: THE FINANCE COMMITTEE OF THE ORGANIZATION ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. FORM 990, SCHEDULE K, PART III, LINES 3B, 4, 5, AND 6: SOUTHERN RESEARCH INSTITUTE IS A NOT-FOR-PROFIT, 501(C)(3) ORGANIZATION AFFILIATED WITH THE UNIVERSITY OF ALABAMA AT BIRMINGHAM. THE ORGANIZATION PROVIDES SERVICES AND SUPPORT FOR BASIC RESEARCH AS WELL AS FOR DRUG DISCOVERY, PRE-CLINICAL DRUG DEVELOPMENT AND ADVANCED ENGINEERING RESEARCH AND DEVELOPMENT. THE ORGANIZATION'S ONLY OUTSTANDING TAX-EXEMPT OBLIGATION IS THE $20,000,000 RECOVERY ZONE FACILITY REVENUE NOTE (SOUTHERN RESEARCH INSTITUTE PROJECT) ISSUED BY THE COOPERATIVE DISTRICT OF THE CITY OF BIRMINGHAM - SOUTHERN RESEARCH INSTITUTE (THE "SERIES 2011 NOTE") REFERENCED IN PART I OF SCHEDULE K TO THE FORM 990 TO WHICH THIS SCHEDULE O IS ATTACHED. THE SERIES 2011 NOTE CONSTITUTES "RECOVERY ZONE FACILITY BONDS" UNDER SECTION 1400U-3 OF THE INTERNAL REVENUE CODE (THE "IRC") AND, AS SUCH, ARE EXEMPT FACILITY BONDS FOR WHICH PRIVATE ACTIVITY IS PERMITTED IN THE CONDUCT OF A "QUALIFIED BUSINESS," WHICH INCLUDES ANY TRADE OR BUSINESS EXCEPT RENTAL REAL ESTATE AND ACTIVITIES PROHIBITED BY IRC SECTION 144(C)(6). THE ORGANIZATION REASONABLY EXPECTS THAT ALL SERVICES PROVIDED IN THE NOTE-FINANCED FACILITIES WILL FALL WITHIN ITS 501(C)(3) MISSION AND WILL CONSTITUTE A "QUALIFIED BUSINESS" UNDER IRC SECTION 1400U-3, AND THE ORGANIZATION REASONABLY EXPECTS THAT OVER THE TERM OF THE SERIES 2011 NOTE, RESEARCH AGREEMENTS IN THE ORDINARY COURSE OF ITS BUSINESS MAY RESULT IN PRIVATE USE OF THE NOTE-FINANCED FACILITIES IN EXCESS OF THE 5% PERMITTED FOR 501(C)(3) OBLIGATIONS. BECAUSE PRIVATE ACTIVITY IS PERMITTED FOR RECOVERY ZONE FACILITY BONDS, HOWEVER, THE ORGANIZATION DOES NOT EXPECT TO TRACK PRIVATE ACTIVITY OR THE NOTE-FINANCED FACILITIES FOR PURPOSES OF ITS BOND COMPLIANCE PROGRAM. BIOSAFETY SOLUTIONS LLC 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 35205 262310782 SAFETY & HEALTH RISK MANAGEMENT COMPANY AL N/A UNIVERSITY OF ALABAMA AT BIRMINGHAM 1530 THIRD AVENUE SOUTH BIRMINGHAM AL 352941150 636005396 HIGHER EDUCATON FACILITY AL POLITICAL SUBDV N/A 0 SOUTHERN RESEARCH INSTITUTE VEBA 2000 NINTH AVENUE SOUTH BIRMINGHAM AL 35205 562439567 VOLUNTARY EMPLOYEE BENEFIT ASSOCIATION AL 501(C)(9) N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0